Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort
- PMID: 33738545
- PMCID: PMC11801995
- DOI: 10.1007/s00432-021-03576-9
Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort
Abstract
Purpose: Parathyroid carcinoma (PC) is an exceedingly rare endocrine malignancy with a poor prognosis. Due to the rarity, the natural course and prognostic factors of the disease are yet unclear. Therefore, we aimed to identify the incidence, prognosis, and prognostic factors of PC in the nationwide cohort study.
Methods: The study is a nationwide study using the National Health Insurance Services database in Korea from 2002 to 2017. PC was defined as patients with ICD-10 code of PC and a procedural code for parathyroidectomy.
Results: From 2002 to 2017, 255 patients were diagnosed with PC whose mean age was 53.2 years, and 155 (60.2%) were women. The crude and age-standardized incidence were 10.2 and 6.6/10,000,000 person-year in 2016, rising from 4.1 and 3.8/10,000,000 person-year in 2003 (p < 0.001), respectively. The 5- and 10-year survival rates were 86.5 and 72.9%, respectively. In survival analysis, age over 50 years, thyroidectomy at the initial surgery, and reoperation had increased risk of mortality with HRs of 4.83 (95% CI 1.47-15.90), and 4.21 (95% CI 1.60-11.08), and 1.05 (95% CI 1.02-1.08) in multivariate analysis, respectively.
Conclusion: Incidence of PC has been rising over time, similar to the trends in Western countries. The prognostic factors for mortality were old age, parathyroidectomy alone, and recurrence, emphasizing the importance of preoperative suspicion of the disease. The study is clinically meaningful in the first Asian nationwide study to reveal the natural course of PC.
Keywords: Cohort; Nationwide; Parathyroid carcinoma; Prognosis.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
SHK, JHK, MYP, SWK, and CSS declare that they have no conflict of interest.
Figures
Similar articles
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Surgical Hip Dislocation in the Era of Hip Arthroscopy Demonstrates High Survivorship and Improvements in Patient-reported Outcomes for Complex Femoroacetabular Impingement.Clin Orthop Relat Res. 2024 Sep 1;482(9):1671-1682. doi: 10.1097/CORR.0000000000003032. Epub 2024 Mar 21. Clin Orthop Relat Res. 2024. PMID: 38513108
-
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22. Clin Orthop Relat Res. 2024. PMID: 38517402
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Undernutrition as a risk factor for tuberculosis disease.Cochrane Database Syst Rev. 2024 Jun 11;6(6):CD015890. doi: 10.1002/14651858.CD015890.pub2. Cochrane Database Syst Rev. 2024. PMID: 38860538 Free PMC article.
Cited by
-
Functional and nonfunctional parathyroid carcinoma: two case reports and literature review.Discov Oncol. 2023 Nov 29;14(1):216. doi: 10.1007/s12672-023-00841-w. Discov Oncol. 2023. PMID: 38019325 Free PMC article.
-
A Nomogram Predicting the Overall Survival and Cancer-Specific Survival in Patients with Parathyroid Cancer: A Retrospective Study.Front Endocrinol (Lausanne). 2022 May 19;13:850457. doi: 10.3389/fendo.2022.850457. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35663321 Free PMC article.
-
Evaluation of factors predicting postoperative recurrence and metastasis of parathyroid cancer: a single-center study.World J Surg Oncol. 2023 Feb 3;21(1):32. doi: 10.1186/s12957-023-02912-2. World J Surg Oncol. 2023. PMID: 36737774 Free PMC article.
-
The Clinical Features and Treatment Strategy of Parathyroid Cancer: A Retrospective Analysis.Biomed Res Int. 2022 Sep 23;2022:1913900. doi: 10.1155/2022/1913900. eCollection 2022. Biomed Res Int. 2022. PMID: 36193301 Free PMC article.
-
Predictive Ability of Rule of 3 in Parathyroid Cancer: Outcomes from a South Asian Cohort.Oncology. 2025;103(5):380-388. doi: 10.1159/000541543. Epub 2024 Sep 19. Oncology. 2025. PMID: 39299227 Free PMC article.
References
-
- Brown S et al (2011) Parathyroid carcinoma: increasing incidence and changing presentation. ANZ J Surg 81:528–532. 10.1111/j.1445-2197.2010.05594.x - PubMed
-
- Busaidy NL et al (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726. 10.1002/hed.20049 - PubMed
-
- DeLellis RA (2004) Pathology and genetics of tumours of endocrine organs, vol 8. IARC, Lyon
-
- Harari A et al (2011) Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab 96:3679–3686. 10.1210/jc.2011-1571 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources